From Name:
From Email:
To Name:
To Email:

Optional Message:

FDA approves first device to treat opioid withdrawal

from MedPage Today

A first-in-class neurostimulation device to relieve symptoms of opioid withdrawal is approved for marketing, the U.S. Food and Drug Administration announced Nov. 15. The NSS-2 Bridge device is a small, battery-powered electrical nerve stimulator that is placed behind a patient's ear and emits electrical pulses to stimulate branches of certain cranial nerves. Patients can use the device for up to five days during the acute physical withdrawal phase. more

Powered by MultiBriefs
7701 Las Colinas Blvd., Ste. 800, Irving, TX 75063